Acute lung injury as a possible adverse drug reaction related to gefitinib

Ieki R., Saitoh E., Shibuya M.

Source: Eur Respir J 2002 Jan 01;22(1):179-181
Journal Issue: July

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Ieki R., Saitoh E., Shibuya M.. Acute lung injury as a possible adverse drug reaction related to gefitinib. Eur Respir J 2002 Jan 01;22(1):179-181

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Drug-induced ILD
Source: Annual Congress 2007 - PG5 - Interstitial lung diseases: known causes and systemic disorders
Year: 2007


A novel approach for optimal lung recruitment in acute lung injury
Source: Annual Congress 2005 - Pulmonary function outcome, respiratory morbidity in prematurely born children and acute lung injury
Year: 2005


Ventilator-associated lung injury: a search for better therapeutic targets
Source: Eur Respir J 2007; 30: 1216-1226
Year: 2007



Pre-treatment with mesenchymal stem cells reduces ventilator-induced lung injury},
Source: Eur Respir J 2012; 40: 939-948
Year: 2012



Pivotal role of the HMGB1/sRAGE axis in drug-induced lung injury in advanced lung cancer with pre-existing interstitial lung disease
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020


Sulphasalazine and lung toxicity
Source: Eur Respir J 2002; 19: 756-764
Year: 2002



Surfactant therapy for acute lung injury and other lung diseases
Source: Eur Respir J 2003; 22: Suppl. 45, 210s
Year: 2003

Salmeterol prevents pneumonia and reduces biomarkers of inflammation/epithelial damage but not acute lung injury following oesophagectomy-the results of BALTI-prevention trial
Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights
Year: 2013

Early short-term versus prolonged low-dose methylprednisolone therapy in acute lung injury
Source: Eur Respir J 2009; 33: 634-645
Year: 2009



Drug-induced infiltrative lung disease
Source: Eur Respir J 2001; 18: 93S-100S
Year: 2001



Mechanisms of acute lung injury
Source: Annual Congress 2005 - In vivo - approaches to lung injury
Year: 2005

Acute lung injury: how the lung inflammatory response works
Source: Eur Respir J 2003; 22: 22S-23S
Year: 2003


A difficult case of acute lung injury
Source: Virtual Congress 2021 – CCC Interstitial lung diseases
Year: 2021


A case series study on re-treatment to lung cancer after drug-induced interstitial lung disease
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018



The effect of mercaptoethylguanidine on acute lung injury associated with sepsis
Source: Eur Respir J 2003; 22: Suppl. 45, 451s
Year: 2003

Perioperative alveolar epithelial damage is a determinant of early acute lung injury (ALI) following oesophagectomy
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010

Delayed neutrophil apoptosis may predispose to lung injury in chronic lung disease of prematurity
Source: Eur Respir J 2007; 30: Suppl. 51, 393s
Year: 2007

Time course of lung parenchyma remodelling in different models of extrapulmonary acute lung injury
Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Year: 2008

The use of surfactant in severe reperfusion injury after lung transplantation
Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation
Year: 2005


Desferrioxamine attenuates minor lung injury following surgical acute liver failure
Source: Eur Respir J 2009; 33: 1429-1436
Year: 2009